Expert consensus on risk prevention and control of multiple drug use in elderly patients with cardiovascular diseases and neuropsychiatric diseases
- VernacularTitle:老年人心血管疾病合并神经精神疾病多重用药风险防控专家共识
- Author:
Association CHINESE
1
Author Information
1. Chinese Society of Clinical Pharmacy of Chinese Medical Association
- Publication Type:Journal Article
- Keywords:
the elderly;
multiple drug use;
risk prevention and control;
cardiovascular disease;
neuropsychiatric disease
- From:
China Pharmacy
2022;33(23):2817-2825
- CountryChina
- Language:Chinese
-
Abstract:
Multiple drug use is very common in the elderly， which will significantly increase drug interactions and adverse drug reactions. Cardiovascular disease complicated with neuropsychiatric disease is the most common multi-disease comorbidity among the elderly， and it is also one of the disease combinations involving the most multiple drug use. In order to reduce the adverse clinical outcomes of the elderly in China， Chinese Society of Clinical Pharmacy of Chinese Medical Association organized relevant experts to develop Expert Consensus on Risk Prevention and Control of Multiple Drug Use in Elderly Patients with Cardiovascular Diseases and Neuropsychiatric Diseases in China by using foreign drug use risk assessment tools and combining relevant evidence-based results， and further promote its application in clinical disease treatment practice to reduce the adverse clinical outcomes of the elderly in China.
